EAM Investors’s Cumberland Pharmaceuticals CPIX Stock Holding History

EAM Investors’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-71,776	Closed	-$304K	–	255
2025 Q1	$304K	Buy	+71,776	New	+$298K	0.05%	245

Other funds holding CPIX

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EAM Investors's CPIX Position: Q2 2025 in Review

EAM Investors sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2025, closing a stake of 71,776 shares — an estimated $304K sold.

EAM Investors first reported a position in CPIX in Q1 2025 and held it in 1 quarter. The position peaked at $304K in Q1 2025. 31 funds tracked by Wall St. Rank hold CPIX as of Q2 2025.

EAM Investors reported no remaining Cumberland Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
EAM Investors sold 71,776 Cumberland Pharmaceuticals shares in Q2 2025, an estimated $304K.
EAM Investors first reported a position in Cumberland Pharmaceuticals in Q1 2025 and held it in 1 quarter.
EAM Investors's Cumberland Pharmaceuticals position peaked at $304K in Q1 2025.
31 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2025.

Based on EAM Investors's 13F filing for Q2 2025, filed 12 Aug 2025.